The amount of clinical proof for the efficacy of Tomosynthesis in screening is
significantly larger than the proof available in the early days of the transition from
analog mammography to FFDM.
Results from studies in Europe using Tomosynthesis
in population based screening and results from screening with Tomosynthesis in the
USA are concordant around an increase in invasive cancer detection and a reduction
in recall rates. As screening programs begin the adoption of Tomosynthesis, many
questions arise around the practical implementation of the technology; however,
current literature is primarily focused around the clinical results.
Presenters at the
symposium will share their experiences with the challenges, the solutions and the
early results from implementing Tomosynthesis in primary screening for breast cancer.
Friday, March 6th
14:00 - 15.30
Room C
Moderator of Session:
Prof. emer. Per Skaane
Speakers/Presentations:
Sarah M. Friedewald, MD. Chicago, USA
The American experience
Dra. Marina Álvarez Benito / Dra. Sara Romero.
Córdoba, España
The Spanish experience
Dott.ssa Daniela Bernardi. Trento, Italia
The Italian experience
Prof.emer. Per Skaane. Oslo, Norge
The Norwegian experience
«« Ultrasound Lags MRI for Supplemental Breast Cancer Screening
Lower Smoking Rate But Higher Lung Cancer Mortality? »»
-
Decision-making in the ICU is a multifaceted process that involves clinical assessment, collaboration among multidisciplinary teams, ethical considerations, evidence-based practice, communication, and continuous adaptation to evolving clinical scenarios. Balancing the complex factors requires
READ MORE
-
When the stakes are high, and the path ahead is uncertain, the decisions made, especially if a patient continues to worsen, can be sources of self-torment and can haunt us for a long time. Our goal is to suggest ways to steer decision-making for intensivists in the face of uncertainty by prop
READ MORE
-
COVID-19 was an emergency that lasted for years and left few regions of the world untouched. The pandemic shone a spotlight on both the strengths and weaknesses of our disaster planning. What worked, what did not, and how can we better plan for future emergencies?
The COVID-19 pandemic fo
READ MORE
Screening, Breast, Tomosynthesis, Hologic, breast cancer screening, breast imaging, #ECR15
The amount of clinical proof for the efficacy of Tomosynthesis in screening is significantly larger than the proof available in the early days of the...
